As of 2025-07-17, the Fair Value of Landos Biopharma Inc (LABP) is -39.61 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 22.93 USD, the upside of Landos Biopharma Inc is -272.74%.
With the market price of 22.93 USD and our fair value calculation, Landos Biopharma Inc (LABP) is not a good investment. Investing in LABP stocks now will result in a potential loss of 272.74%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 5Y Avg | |
| Net income | -13.47 | -30.14 | -38.42 | -39.28 | -21.93 | -28.65 |
| YoY growth | -123.01% | -123.76% | -27.47% | -2.24% | 44.16% | -46.46% |
| Market Cap (mil) | 71.77 |
| P/E | |
| Forward P/E |
| EPS | -7.92 |
| Avg earnings growth rate | -46.46% |
| TTM earnings | -24.80 |